Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian Loffredo

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Prostate Cancer|May 16, 2014
Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened CohortShyam K Tanguturi, Ming-Hui Chen, Marian Loffredo, et al.
Prostate Cancer|May 28, 2014
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate CancerLior Z Braunstein, Ming-Hui Chen, Marian Loffredo, et al.
Cancer|November 5, 2008
Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancerAnthony V D'Amico, Ming-Hui Chen, Andrew A Renshaw, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Predictors of mortality after prostate-specific antigen failureAnthony V D'Amico, Phillip Kantoff, Marian Loffredo, et al.
JAMA|August 19, 2004
6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trialAnthony V D'Amico, Judith Manola, Marian Loffredo, et al.
Archives of Pathology & Laboratory Medicine|July 23, 2003
Accurate Gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologistsAndrew A Renshaw, Delray Schultz, Kerri Cote, et al.
Urology|November 16, 2005
Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancerClair Beard, Ming-Hui Chen, Kerri Cote, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancerAnthony V D'Amico, Aparna Keshaviah, Judith Manola, et al.
Urology|March 27, 2007
Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancerStephanie C Krejcarek, Ming-Hui Chen, Andrew A Renshaw, et al.
Cancer|September 30, 2006
Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancerJoshua H Petit, Ming-Hui Chen, Marian Loffredo, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Prostate Cancer|May 16, 2014
Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened CohortShyam K Tanguturi, Ming-Hui Chen, Marian Loffredo, et al.
Prostate Cancer|May 28, 2014
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate CancerLior Z Braunstein, Ming-Hui Chen, Marian Loffredo, et al.
Cancer|November 5, 2008
Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancerAnthony V D'Amico, Ming-Hui Chen, Andrew A Renshaw, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Predictors of mortality after prostate-specific antigen failureAnthony V D'Amico, Phillip Kantoff, Marian Loffredo, et al.
JAMA|August 19, 2004
6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trialAnthony V D'Amico, Judith Manola, Marian Loffredo, et al.
Archives of Pathology & Laboratory Medicine|July 23, 2003
Accurate Gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologistsAndrew A Renshaw, Delray Schultz, Kerri Cote, et al.
Urology|November 16, 2005
Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancerClair Beard, Ming-Hui Chen, Kerri Cote, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancerAnthony V D'Amico, Aparna Keshaviah, Judith Manola, et al.
Urology|March 27, 2007
Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancerStephanie C Krejcarek, Ming-Hui Chen, Andrew A Renshaw, et al.
Cancer|September 30, 2006
Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancerJoshua H Petit, Ming-Hui Chen, Marian Loffredo, et al.
Pageof 6